When Cancer Drugs Run Short, Patients Feel the Gap
A Washington Post report describes how some U.S. cancer patients and clinicians are turning to overseas sources when key medicines run short. The broader pattern reflects a stubborn reality: shortages can delay treatment, force substitutions, and create new safety questions.